Hikma Pharmaceutical | HIK - Assets



Hikma Pharmaceutical reported $5.13B in Assets for its fiscal semester ending in December of 2024.


Assets Change Date
Almirall EUR 2.31B 88.18M Jun/2025
argenx SE 7.18B 973.07M Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
Autolus Therapeutics Ltd 720.98M 25.36M Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Fresenius EUR 41.32B 1.89B Jun/2025
Galapagos EUR 3.82B 203.72M Jun/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
GRIFOLS EUR 19.77B 1.21B Jun/2025
Hikma Pharmaceutical USD 5.13B 286M Dec/2024
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 47.35B 2.02B Jun/2025
Orion EUR 1.65B 56M Jun/2025
Recordati EUR 5.18B 9.99M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sanofi 124.96B 6.93B Jun/2025
UCB EUR 17.35B 1.72B Dec/2024